Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 46,850
-800 (-1.68%)
At close: Aug 12, 2026
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 354.32 billion as of August 12, 2026.
Market Cap
354.32B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
46,850.00
ChartMarket Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 354.32B, an increase of 57.78%. That is a compound annual growth rate of 89.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 354.32B | -9.24% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CLASSYS | 3.02T |
| L&C BIO Co.,LTD | 1.71T |
| SD Biosensor | 793.08B |
| T&L Co., Ltd. | 533.94B |
| BioNote | 502.92B |
| Vieworks | 224.07B |
| Dongbang Medical | 136.28B |
| Shinhung | 129.09B |